- Report
- March 2025
- 441 Pages
Global
From €10510EUR$12,000USD£9,122GBP
- Report
- February 2025
- 376 Pages
Global
From €4335EUR$4,950USD£3,763GBP
- Report
- May 2025
- 138 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- July 2025
- 175 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- February 2026
- 372 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 196 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- January 2026
- 110 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- July 2025
- 88 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- December 2024
- 260 Pages
Global
From €4335EUR$4,950USD£3,763GBP
The Reverse Shoulder Arthroplasty (RSA) market is a segment of the Orthopedic Devices industry. RSA is a surgical procedure used to treat shoulder joint problems, such as rotator cuff tears, shoulder fractures, and shoulder arthritis. It involves replacing the shoulder joint with an artificial joint, which is composed of a metal ball and a plastic socket. The procedure is used to restore shoulder function and reduce pain.
RSA is a relatively new procedure, and the market is still in its early stages. However, it is growing rapidly due to its effectiveness in treating shoulder joint problems. The market is expected to benefit from the increasing prevalence of shoulder joint problems, as well as the growing demand for minimally invasive procedures.
The RSA market is highly competitive, with several major players. These include Zimmer Biomet, Stryker, Smith & Nephew, and DePuy Synthes. These companies are investing heavily in research and development to develop new products and technologies to improve the effectiveness of the procedure. Show Less Read more